Evolving Utilization of Donation After Circulatory Death Livers in Liver Transplantation: The Day of DCD Has Come

Overview

Journal Clin Transplant

Specialty General Surgery

Date 2020 Dec 28

PMID 33368701

Citations 15

Authors

Omar Haque

Qing Yuan

Korkut Uygun

James F Markmann

Affiliations

Soon will be listed here.

Abstract

Compared to donation after brain death (DBD), livers procured for transplantation from donation after circulatory death (DCD) donors experience more ischemia-reperfusion injury and higher rates of ischemic cholangiopathy due to the period of warm ischemic time (WIT) following withdrawal of life support. As a result, utilization of DCD livers for liver transplant (LT) has generally been limited to short WITs and younger aged donor grafts, causing many recovered DCD organs to be discarded without consideration for transplant. This study assesses how DCD liver utilization and outcomes have changed over time, using OPTN data from adult, first-time, deceased donor, whole-organ LTs between January 1995 and December 2019. Results show that increased clinical experience with DCD LT has translated into increased use of livers from DCD donors, shorter ischemic times, shorter lengths of hospitalization after transplant, and lower rates of retransplantation. The data also reveal that over the past decade, the rate of increase in DCD LTs conducted in the United States has outpaced that of DBD. Together, these trends signal an opportunity for the field of liver transplantation to mitigate the organ shortage by capitalizing on DCD liver allografts that are currently not being utilized.

Citing Articles

Thoracoabdominal Normothermic Regional Perfusion: Real-world Experience and Outcomes of DCD Liver Transplantation.

Bababekov Y, Ha A, Nydam T, Goncalves C, Choudhury R, Shinsako J Transplant Direct. 2025; 11(3):e1767.

PMID: 40034160 PMC: 11875611. DOI: 10.1097/TXD.0000000000001767.

Improved Outcomes of Liver Transplantation in Patients With Hepatitis C, Following the Introduction of Innovative Antiviral Therapies.

Moein M, Fioramonti P, Lieb K, Golkarieh A, Forouzan A, Leipman J J Clin Exp Hepatol. 2024; 15(1):102428.

PMID: 39564427 PMC: 11570942. DOI: 10.1016/j.jceh.2024.102428.

Optimized partial freezing protocol enables 10-day storage of rat livers.

Ozgur O, Taggart M, Mojoudi M, Pendexter C, Filz von Reiterdank I, Kharga A Sci Rep. 2024; 14(1):25260.

PMID: 39448774 PMC: 11502795. DOI: 10.1038/s41598-024-76674-6.

Current status of simultaneous liver-kidney transplantation.

Ali H, Begum Ozturk N, Herdan N, Luu H, Simsek C, Kazancioglu R Hepatol Forum. 2024; 5(4):207-210.

PMID: 39355834 PMC: 11440222. DOI: 10.14744/hf.2023.2023.0071.

Normothermic Regional Perfusion in Controlled Donation After Circulatory Death Liver Transplantation: A Systematic Review and Meta-Analysis.

Mastrovangelis C, Frost C, Hort A, Laurence J, Pang T, Pleass H Transpl Int. 2024; 37:13263.

PMID: 39246548 PMC: 11377255. DOI: 10.3389/ti.2024.13263.

References

Fujita S, Mizuno S, Fujikawa T, Reed A, Kim R, Howard R . Liver transplantation from donation after cardiac death: a single center experience. Transplantation. 2007; 84(1):46-9. DOI: 10.1097/01.tp.0000267424.88023.7b. View

Zhang Z, Kim H, Lonjon G, Zhu Y . Balance diagnostics after propensity score matching. Ann Transl Med. 2019; 7(1):16. PMC: 6351359. DOI: 10.21037/atm.2018.12.10. View

Croome K, Lee D, Keaveny A, Taner C . Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors. Transplantation. 2016; 100(12):2640-2647. DOI: 10.1097/TP.0000000000001483. View

Mathur A, Heimbach J, Steffick D, Sonnenday C, Goodrich N, Merion R . Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant. 2010; 10(11):2512-9. DOI: 10.1111/j.1600-6143.2010.03293.x. View

Manzarbeitia C, Ortiz J, Jeon H, Rothstein K, Martinez O, Araya V . Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation. 2004; 78(2):211-5. DOI: 10.1097/01.tp.0000128327.95311.e3. View

Watson C, Kosmoliaptsis V, Pley C, Randle L, Fear C, Crick K . Observations on the ex situ perfusion of livers for transplantation. Am J Transplant. 2018; 18(8):2005-2020. PMC: 6099221. DOI: 10.1111/ajt.14687. View

Ho K, Owens C, Johnson S, Khwaja K, Curry M, Pavlakis M . Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation. 2008; 85(11):1588-94. DOI: 10.1097/TP.0b013e318170b6bb. View

Schlegel A, Kalisvaart M, Scalera I, Laing R, Mergental H, Mirza D . The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation. J Hepatol. 2017; 68(3):456-464. DOI: 10.1016/j.jhep.2017.10.034. View

Taylor R, Allen E, Richards J, Goh M, Neuberger J, Collett D . Survival advantage for patients accepting the offer of a circulatory death liver transplant. J Hepatol. 2019; 70(5):855-865. DOI: 10.1016/j.jhep.2018.12.033. View

10.

Hobeika M, Menser T, Nguyen D, Beal L, Zajac S, Graviss E . United States donation after circulatory death liver transplantation is driven by a few high-utilization transplant centers. Am J Transplant. 2019; 20(1):320-321. DOI: 10.1111/ajt.15629. View

11.

Schlegel A, Dutkowski P . Role of hypothermic machine perfusion in liver transplantation. Transpl Int. 2014; 28(6):677-89. DOI: 10.1111/tri.12354. View

12.

Detry O, Seydel B, Delbouille M, Monard J, Hans M, De Roover A . Liver transplant donation after cardiac death: experience at the University of Liege. Transplant Proc. 2009; 41(2):582-4. DOI: 10.1016/j.transproceed.2009.01.001. View

13.

Taner C, Bulatao I, Willingham D, Perry D, Sibulesky L, Pungpapong S . Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl. 2011; 18(1):100-11. DOI: 10.1002/lt.22404. View

14.

Le Dinh H, De Roover A, Kaba A, Lauwick S, Joris J, Delwaide J . Donation after cardio-circulatory death liver transplantation. World J Gastroenterol. 2012; 18(33):4491-506. PMC: 3435774. DOI: 10.3748/wjg.v18.i33.4491. View

15.

ONeill S, Roebuck A, Khoo E, Wigmore S, Harrison E . A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int. 2014; 27(11):1159-74. DOI: 10.1111/tri.12403. View

16.

Jay C, Skaro A, Ladner D, Wang E, Lyuksemburg V, Chang Y . Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl. 2012; 18(6):630-40. PMC: 3365831. DOI: 10.1002/lt.23418. View

17.

Foley D, Fernandez L, Leverson G, Chin L, Krieger N, Cooper J . Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg. 2005; 242(5):724-31. PMC: 1409855. DOI: 10.1097/01.sla.0000186178.07110.92. View

18.

Austin P . The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2013; 33(7):1242-58. PMC: 4285179. DOI: 10.1002/sim.5984. View

19.

Op den Dries S, Westerkamp A, Karimian N, Gouw A, Bruinsma B, Markmann J . Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures. J Hepatol. 2014; 60(6):1172-9. DOI: 10.1016/j.jhep.2014.02.010. View

20.

Bral M, Gala-Lopez B, Bigam D, Kneteman N, Malcolm A, Livingstone S . Preliminary Single-Center Canadian Experience of Human Normothermic Ex Vivo Liver Perfusion: Results of a Clinical Trial. Am J Transplant. 2016; 17(4):1071-1080. DOI: 10.1111/ajt.14049. View